Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Receivables - Other (2017 - 2025)

Historic Receivables - Other for Dare Bioscience (DARE) over the last 7 years, with Q3 2025 value amounting to $369157.0.

  • Dare Bioscience's Receivables - Other fell 2885.59% to $369157.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $369157.0, marking a year-over-year decrease of 2885.59%. This contributed to the annual value of $229982.0 for FY2024, which is 7577.12% down from last year.
  • As of Q3 2025, Dare Bioscience's Receivables - Other stood at $369157.0, which was down 2885.59% from $188116.0 recorded in Q2 2025.
  • Over the past 5 years, Dare Bioscience's Receivables - Other peaked at $3.0 million during Q2 2021, and registered a low of $105234.0 during Q1 2025.
  • Its 5-year average for Receivables - Other is $1.1 million, with a median of $949211.0 in 2023.
  • In the last 5 years, Dare Bioscience's Receivables - Other surged by 156847.79% in 2021 and then plummeted by 9240.56% in 2025.
  • Quarter analysis of 5 years shows Dare Bioscience's Receivables - Other stood at $1.1 million in 2021, then skyrocketed by 48.71% to $1.7 million in 2022, then crashed by 44.27% to $949211.0 in 2023, then plummeted by 75.77% to $229982.0 in 2024, then skyrocketed by 60.52% to $369157.0 in 2025.
  • Its last three reported values are $369157.0 in Q3 2025, $188116.0 for Q2 2025, and $105234.0 during Q1 2025.